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Abstract
Background: Septic shock is the first cause of death in Intensive Care Units. Despite experimental data showing
increased inflammatory response of aged animals following infection, the current accepted hypothesis claims that
aged patients are immunocompromised, when compared to young individuals.
Results: Here, we describe a prospective cohort study designed to analyze the immune profile of this population.
Conclusion: Older people are as immunocompetent as the young individual, regarding the cytokines, chemokines
and growth factors response to devastating infection.
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Background
Ageing is a growing field of medical research, since this
process is strongly related with diseases such as athero-
sclerosis, Alzheimer’s Disease, type 2 diabetes and other
main causes of death worldwide. Older age is associated
with chronically elevated circulating levels of inflammatory
markers, such as tumor necrosis factor (TNFα), IL-1β, IL-6
and C-reactive protein (CRP) [1]. Immunosenescence
seems to influence many components of the immune
system. Profound changes in T cell function have been de-
scribed in older individuals [2,3], especially in Th17 and
regulatory T cells activity [2,4]. Regarding innate immunity,
age-associated alterations have been described in macro-
phages, natural-killer and polymorphonuclear cells [5,6].
Discrepant results, however, are frequently observed [7].
While some authors have detected an increase in cytokine
production [8], for example, others have described oppos-
ing results [9].
Sepsis is a disease of older people. Indeed, 60% of all
sepsis events and 80% of septic deaths occur in individ-
uals over 65 years-old [10]. The incidence increases ex-
ponentially with age and older age is an independent
risk factor for mortality among adults hospitalized with
sepsis [11]. A recent prospective cohort study of patients
hospitalized with pneumonia-induced sepsis found an
age-related increase in in-hospital, 90-day and 1-year
post-discharge mortality [12].
The reason for the higher susceptibility to infection
and the higher risk of severe sepsis and mortality in
older adults, however, remain unclear [13]. Here, we in-
vestigate the cytokine profile of aged individuals compared
to young adults, during the development of overwhelming
infection, in order to characterize the immune status of
this population.
Results
We included 73 patients in this study protocol (44 pa-
tients admitted in the ICU for non-infectious reasons
and 29 admitted for septic shock) between October 2010
and October 2012. In our study, patients in the ICU
control and septic shock groups showed similar profile
when young and aged patients were compared. Sex
distribution was similar in both groups. Regarding the
population characteristics (Table 1), elderly patients in
the septic shock group showed worst renal function than
young patients in the same group (p = 0.017), as
accessed by creatinin plasma levels. Both young and
aged patients showed similar sodium, potassium, magne-
sium, phosphate and chloride plasma levels, whether in
the ICU or septic shock group. Calcium, a marker of
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severity of disease [14], was significantly lower in aged
septic individuals than in aged controls (p = 0.043), but
not than in young septic patients (p = 0.294). Hemoglobin
(Hb) and hematocrit (Ht) levels significantly decreased in
young septic patients compared to controls, but not in
aged patients. Leukocytes and polymorponuclear cells
(PMNs) significantly rose in young septic group compared
to controls, but not in the elderly group. Platelets levels
were similar in all study groups. Albumin significantly de-
creased in septic shock when compared to ICU controls,
but young and aged patients showed similar albumin
levels (p = 0.708). Lactate significantly rose in young, but
not in the elderly, when patients in septic shock were
compared to controls. The same profile was found for C-
reactive protein levels. SOFA score and mortality were
similar for the young and the older age septic groups (p =
0.517 and 0.986).
Cytokines profile showed activation of innate immun-
ity and polyclonal activation of T cells in the young
during septic shock, characterized by a rise in TNFα, IL-
1β, IL-6, IL-4, IL-17 and interferon-γ when compared to
the ICU control group. No differences, however, could
be detected when the young in septic shock (group A)
was compared to the elderly in septic shock (group B)
(Table 2). Chemokines and growth factors also showed
similar values when the elderly was compared to young
subjects (Table 3).
Discussion
Older age has been widely characterized as a pro-
inflammatory state [15]. Animal models of infection also
support that older subjects have higher circulating levels
of inflammatory markers. Tateda et al. have shown that
aged mice exhibit higher TNFα, IL-1β and IL-6 levels
than young mice after intraperitoneal injection of LPS
[16]. Using the cecal ligation and puncture model (CLP),
Turnbull et al. also found similar results [17]. The under-
lying mechanism of the vulnerability to infections of the
elderly has been ascribed to the breakdown of anatomic
barriers, underlying illnesses or the declining capacity of
the immune system [18], while latent infections such as
cytomegalovirus (CMV) may act as chronic stimuli of the
inflammatory system [19,20]. Persistent inflammation has
been shown to increase the risk of bacterial invasion in
rodents by reducing neutrophil recruitment and bacterial
clearance [21,22]. Turnbull et al. proposed that macro-
phages of aged mice may be relatively activated, or
primed, for cytokine production prior to LPS challenge.
There have been, however, several conflicting reports,
when in vitro production of cytokines by aged cells is
Table 1 Population characteristics
Young Elderly Group A vs. B
Control n=36 Septic shock
(group A) n=21
p-value Control n=8 Septic shock
(group B) n=8
p-value p-value
age (yrs) 45 ± 11 40 ± 13 0.154 73 ± 6 75 ± 9 0.666 0.000
male sex 38% 50 0.454 50 62% 0.766
creatinin (mg/dl) 1.50 ± 2.73 1.04 ± 1.24 0.523 1.50 ± 1.60 2.62 ± 1.40 0.173 0.017
sodium (meq/dl) 142 ± 11 139 ± 9 0.133 141 ± 6 146 ± 18 0.454 0.283
potassium (meq/dl) 3.52 ± 0.84 3.52 ± 1.16 0.988 3.62 ± 0.74 4.25 ± 0.70 0.122 0.055
magnesium (mg/dl) 1.44 ± 0.55 1.19 ± 0.51 0.147 1.38 ± 0.51 1.63 ± 0.51 0.302 0.064
calcium (mg/dl) 4.77 ± 0.86 4.42 ± 0.74 0.100 4.75 ± 0.46 4.12 ± 0.64 0.043 0.294
phosphate (mg/dl) 3.03 ± 1.15 3.86 ± 2.47 0.073 3.75 ± 1.66 4.38 ± 1.92 0.482 0.577
chloride (mg/dl) 107 ± 12 105 ± 7 0.527 108 ± 10 104 ± 6 0.394 0.703
hemoglobin (g/dl) 12 ± 2.0 10 ± 2.2 0.011 10 ± 2.0 10 ± 2.2 0.913 0.939
hematocrit (g/dl) 36 ± 6 30 ± 6 0.010 31 ± 6 32 ± 6 1.000 0.769
leucocytes (/mm3) 10891 ± 4386 15569 ± 13341 0.046 17830 ± 23033 11863 ± 6020 0.499 0.314
PMN cells (/mm3) 8778 ± 4003 12406 ± 10710 0.061 7518 ± 3917 10446 ± 5632 0.231 0.529
platelets (/mm3) 235833 ± 136039 224571 ± 171250 0.769 196500 ± 86663 152750 ± 69134 0.267 0.119
albumin (g/dl) 2.83 ± 0.81 2.04 ± 0.74 0.000 2.62 ± 0.51 2.12 ± 0.35 0.039 0.708
lactate (g/dl) 12.75 ± 6.83 31.61 ± 35.91 0.001 11.25 ± 4.71 19.12 ± 9.32 0.311 0.154
CRP (g/dl) 50 ± 76 139 ± 129 0.003 56 ± 73 96 ± 162 0.494 0.939
SOFA score 3.50 ± 3.12 9.14 ± 4.13 0.000 4.13 ± 3.22 9.25 ± 2.96 0.002 0.517
ICU mortality 11% 47% 0.003 37.5% 50% 0.628 0.939
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investigated [23-26]. In our study, we were also unable to
find any cytokine, chemokine or growth factor that could
serve to better explain the reasons why this population
shows increased susceptibility and mortality to septic
shock. Our results show, moreover, that leukocytosis, CRP
and lactate are good markers of infection to young
patients, but not to the aged one. We suggest that the in-
creased mortality of the elderly described by others may
underlie on the function of non-immune cells. Disruption
of epithelial barriers, malfunction of ciliary cells, malab-
sorption, malnutrition, polimorphisms, deficits of cogni-
tion and associated comorbities, in our opinion, may
Table 2 Cytokines profile
Young Elderly Group A vs. B
Control n=36 Septic shock (group A) n=21 p-value Control n=8 Septic shock (group B) n=8 p-value p-value
IL-1α 31 ± 42 100 ± 82 0.000 27 ± 27 75 ± 82 0.270 0.242
IL-1ϐ 2.50 ± 2.93 7.09 ± 7.11 0.007 1.12 ± 1.35 4.37 ± 6.98 0.480 0.148
IL-1 RA 36 ± 47 192 ± 295 0.001 31 ± 33 145 ± 292 0.114 0.317
IL-2 9.00 ± 6.74 13 ± 10 0.121 4.12 ± 2.10 9.62 ± 5.52 0.023 0.508
IL-3 2.08 ± 2.44 2.61 ± 3.33 0.849 0.62 ± 0.51 2.25 ± 2.54 0.070 0.899
IL-4 8.55 ± 10.60 32 ± 48 0.007 3.87 ± 4.91 16.00 ± 22.35 0.093 0.334
IL-5 2.19 ± 3.24 7.19 ± 9.26 0.010 0.50 ± 1.06 2.87 ± 3.44 0.082 0.208
IL-6 37 ± 63 1641 ± 3195 0.000 32 ± 39 1666 ± 3590 0.036 0.884
IL-7 11 ± 8.26 40 ± 39 0.000 5.62 ± 3.46 34.75 ± 48.70 0.002 0.393
IL-8 29 ± 25 806 ± 2819 0.000 26.25 ± 22.24 1695 ± 4602 0.016 0.354
IL-9 2.08 ± 2.37 4.52 ± 5.06 0.044 0.50 ± 1.06 4.25 ± 6.11 0.043 0.489
IL-10 12 ± 16 626 ± 2195 0.000 38 ± 78 480 ± 1079 0.012 0.575
IL-12p40 39 ± 44 111 ± 80 0.000 31 ± 34 141 ± 214 0.206 0.464
IL-12p70 7.19 ± 4.79 20.61 ± 20.09 0.002 4.50 ± 2.72 10.50 ± 8.79 0.423 0.195
IL-13 4.86 ± 6.51 14.90 ± 32.48 0.119 1.37 ± 1.06 10.87 ± 16.12 0.097 0.583
IL-15 7.38 ± 6.23 20.52 ± 25.30 0.001 4.00 ± 3.20 16.62 ± 18.92 0.011 0.558
IL-17 2.88 ± 2.43 8.66 ± 6.31 0.000 1.87 ± 1.45 6.87 ± 5.46 0.018 0.493
IFNα 67 ± 42 110 ± 58 0.000 195 ± 402 78 ± 38 0.270 0.150
IFNy 7.83 ± 4.45 40.09 ± 52.41 0.000 6.25 ± 5.67 30.87 ± 36.56 0.013 0.574
TFNα 19 ± 21 111 ± 207 0.000 23 ± 20 81 ± 102 0.016 0.770
Table 3 Chemokines and growth factors profile
Young Elderly Group A vs. B
Control n=36 Septic shock (group A) n=21 p-value Control n=8 Septic shock (group B) n=8 p-value p-value
EGF 266 ± 212 212 ± 182 0.264 192 ± 80 250 ± 213 0.600 0.696
FGF2 122 ± 62 133 ± 55 0.301 113 ± 45 153 ± 67 0.344 0.575
FITL3 6.27 ± 11.4 18 ± 165 0.000 6.25 ± 14.04 16 ± 27 0.235 0.104
FRAKTALINE 167 ± 81 573 ± 858 0.001 120 ± 73 296 ± 273 0.027 0.251
GCSF 156 ± 196 3662 ± 7100 0.001 104 ± 106 3226 ± 7166 0.093 0.922
GMCSF 32 ± 21 125 ± 284 0.000 48 ± 65 54 ± 43 0.208 0.241
GRO 1958 ± 1642 2644 ± 3934 0.772 1733 ± 884 4074 ± 4718 0.753 0.435
MCP-1 610 ± 912 2806 ± 4334 0.002 916 ± 1129 3237 ± 4792 0.171 1.0
MCP-3 24 ± 13 58 ± 44 0.001 11.62 ± 5.20 32 ± 25 0.023 0.130
MDC 817 ± 719 714 ± 471 0.869 745 ± 350 625 ± 265 0.208 0.527
MIP-1 23 ± 22 50 ± 65 0.069 322 ± 871 39 ± 25 0.127 0.696
MIP-1 42 ± 25 102 ± 83 0.000 35 ± 31 94 ± 60 0.027 0.678
VEGF 227 ± 306 310 ± 239 0.003 143 ± 115 392 ± 387 0.021 0.678
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play a pivotal role. Interestingly, impaired sympathetic
response has been observed as a partial explanation for
several modifications that occur during ageing [27], in-
cluding increased mortality in septic shock [28].
Sepsis has challenged the medical community for de-
cades. After the negative results of innumerous clinical
trials, when researchers insisted that the disease could
be controlled by inhibition of the pro-inflammatory re-
sponse, a new hypothesis emerged. In 1996, Roger Bone
proposed that early after the explosive inflammatory re-
sponse that characterizes sepsis, a compensatory antag-
onistic response syndrome (CARS) would arise [29],
explaining why anti-inflammatory drugs do not benefit
septic patients and even further increase mortality. It is
important to state that our study looks at the immune
profile at one point in time. It is possible that immune
profiles diverge later in disease. This point is important
later when we talk about CARS, since CARS may still
exist later in the disease course.
Actually, sepsis is considered a heterogenic disease, be-
ing very difficult to reproduce in animal models. Indeed,
at the present time most of the researchers believe that a
systemic inflammatory response syndrome (SIRS) prevails
in young patients, while CARS dominates most of the
septic inflammatory response of older people. In aged pa-
tients, thus, sepsis would be characterized by a dominant
anti-inflammatory response, an immunocompromissed
state [30]. Clinical trials, however, have not confirmed
this hypothesis yet. Our study points out that the elderly
has an efficient immune profile, very similar to the
young patient.
Our study has limitations. The major limitation is the
sample size. A recent clinical study, however, was unable
to find any age-related difference in inflammatory and
cell surface markers in patients hospitalized for pneumo-
nia [12]. Similarly, Kelly et al. found no differences in
the cytokine profile of young, older and very elderly pa-
tient with community-acquired pneumonia [31]. We be-
lieve that our data brings important information and
should be further explored in larger studies. Once con-
firmed, studies of immunosenescence should focus on
defects in phagocytosis, production of reactive oxygen
species, immunoglobulins and other cell functions that
were not addressed by the present study.
Conclusions
Our study describes that aged individuals display a
competent immune profile, regarding the secretion of
cytokines, chemokines and growth factors. Further re-
search is warranted to explain the molecular mecha-
nisms why aged individuals develop higher rates of
infection and might display worse outcomes, a relevant
topic on immune-inflammatory responses in ageing.
Here, we point out that the results in animal models
diverge from clinical research and argue against the
current concept that sepsis in older people is character-
ized by CARS, a massive counter-antagonistic response
to systemic inflammation. Larger studies are necessary
to confirm our data and explore other aspects of im-
munity in this population.
Methods
Study design
The current study was a prospective cohort, conducted
in one of the Hospital das Clinicas Intensive Care Units
(University of Sao Paulo, Brazil). Surgical patients, trauma
and coronary syndromes are usually admitted at other
ICUs from our hospital, what makes our population very
homogeneous. Indeed, the five following reasons account
for more than 90% of the ICU admissions included in this
study: sepsis, stroke, altered level of consciousness, pul-
monary edema and asthma/COPD. Patients less than 18
years old, pregnant, with disseminated malignancies or re-
ceiving chemotherapy, HIV-positive, advanced hepatic dis-
ease, in end-of-life conditions and those that refused to
participate in this study were excluded. The remaining pa-
tients were divided in two groups: 1) ICU control (patients
admitted to the ICU for non-infectious causes); 2) septic
shock group (patients admitted to the ICU for septic
shock or that developed septic shock during the ICU stay).
90% of data from septic elderly were taken on hospital day
1 compared to 90% from elderly controls. Each group was
divided in two sub-groups: under 65 years-old (young
individuals) and above 65 years-old (aged individuals).
Data and blood samples were collected at patient’s ad-
mission or when the diagnosis of severe sepsis or septic
shock was established by the medical staff. SIRS, Severe
sepsis and septic shock were defined, according to the
consensus proposed in 1992 [32]. The protocol was ap-
proved by Hospital das Clinicas Ethical Committee and
patients (or their close relatives) received detailed expla-
nations and provided written consent to be included in
the study protocol.
Statistical analysis
A descriptive analysis of the population (age, sex, elec-
trolytes, SOFA score and mortality) was performed.
SOFA score assesses mortality in the critically ill. Cy-
tokines were analyzed by Miliplex technology (Merck,
Genese diagnostics), a multiplex method for cytokines
analysis. Continuous variables were analyzed by using
Student’s t test or Mann–Whitney test, as appropri-
ated. Categorical variables were analyzed by using chi-
square test. Results were reported as mean ± standard
deviation. All analysis performed used SPSS 19.0 soft-
ware. A p value of .05 was considered to be statisti-
cally significant.
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